We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




HCV-RNA Present in Body Fluids in High Viral Load Patients

By LabMedica International staff writers
Posted on 26 Dec 2018
Hepatitis C virus (HCV) causes both acute and chronic infection. More...
Acute HCV infection is usually asymptomatic, and is only very rarely (if ever) associated with life-threatening disease. About 15%–45% of infected persons spontaneously clear the virus within six months of infection without any treatment.

There is an ongoing epidemic of HCV) infection among men who have sex with men (MSM). Although epidemiological studies observed an association with certain sexual practices and/or concomitant recreational drug use, the underlying mechanisms of HCV transmission via these routes remains poorly defined.

Scientists at the Medical University of Vienna (Vienna, Austria) prospectively enrolled 34 Patients with acute (AHC) or chronic (CHC) HCV infection. Rectal and nasal swabs were obtained in all patients and after calibration and validation of the HCV assay, HCV-RNA levels were quantified in swab samples. Fecal occult blood tests were performed to rule out rectal bleeding. The mean age was 43 ± 8 years, the majority of patients (91%; 31/34) were HIV+ and 82% (28/34) were male of whom 64% (18/28) were MSM. Questionnaires were used to assess risk behavior related to recreational drug use and sexual practices.

AHC was observed in 32% (11/34) with all patients being HIV+MSM and 91% (10/11) having a history of sexually transmitted diseases. The most common HCV-genotype (GT) was GT-1a (50%; 17/34) whereas GT-1b, GT-2, GT-3 and GT-4 were observed in 15% (5/34), 3% (1/34), 21% (7/34) and 12% (4/34), respectively. Twenty-three (68%) patients had at least one positive swab sample (56%; 19/34 nasal and 52%; 17/33 rectal), whereas blood contamination was never detected. Individuals with positive swab sample had significantly higher HCV-RNA viremia versus patients with negative swab sample (6.37 IQR 1.06 log IU/mL versus 4.76 IQR 2.54 log IU/mL.

The authors concluded that HCV-RNA is readily detectable in rectal (despite the absence of fecal occult blood) and nasal fluids in patients with AHC/CHC, independently of HIV status, duration of HCV infection or the suspected route of HCV acquisition. Thus, the data strongly suggest that sharing of nasal drug-sniffing 'tools' and unprotected anal intercourse represent high-risk practices for HCV transmission, especially in patients with high serum HCV-RNA levels.

David Chromy, MD, the lead author of the study, said, “We actually did expect to find HCV RNA in the body fluids of our patients. Still we aimed to carefully rule out contamination of rectal fluid by occult bleeding (as a potential confounder) by performing a respective test for occult fecal blood. These bodily fluids may serve as vectors for transmission, still we strongly believe that additional mucosal trauma and/or bleeding is necessary for transmitting HCV-RNA and thus, HCV infection.” The study was presented at the American Association for the Study of Liver Diseases (AASLD; Liver Meeting) in held November 9-13, 2018, in San Francisco, CA, USA.

Related Links:
Medical University of Vienna


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.